L'ACTIVITÉ PHYSIQUE COMME TRAITEMENT ALTERNATIF DU CHIKUNGUNYA
Mots-clés :
Actividad física, Réhabilitation, Activité physiqueRésumé
Le virus Chikungunya (CHIKV), transmis par le moustique Aedes aegypti, a été initialement identifié à Bangkok en 1958 et est arrivé au Brésil en 2014, suscitant des préoccupations en raison de ses symptômes de longue durée, tels que la fièvre et la douleur polyarticulaire intense. Ces symptômes peuvent évoluer vers un stade chronique, causant une douleur et une raideur articulaire persistantes, affectant la qualité de vie. Le traitement actuel repose principalement sur les anti-inflammatoires non stéroïdiens (AINS). Cependant, des preuves récentes suggèrent que les approches non pharmacologiques, telles que les exercices de résistance et l'hydrothérapie, sont efficaces pour améliorer la fonctionnalité et soulager la douleur chez les patients chroniques. Compte tenu du manque d'attention accordée à la Chikungunya en tant que maladie tropicale négligée, il est essentiel de mettre l'accent sur des traitements intégrés et de développer des politiques publiques qui intègrent des thérapies non pharmacologiques.
Téléchargements
Références
BARTELS, E. M. et al. Aquatic exercise for the treatment of knee and hip osteoarthritis. The Cochrane Database of Systematic Reviews, v. 3, n. 3, p. CD005523, 23 mar. 2016.
BASTOS, M. L. A.; ABREU, F. S. DE; SILVA JUNIOR, G. B. DA. Inability to work due to Chikungunya virus infection: impact on public service during the first epidemic in the State of Ceará, northeastern Brazil. The Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases, v. 22, n. 3, p. 248–249, 2018.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Monitoramento dos casos de arboviroses urbanas transmitidas pelo Aedes (dengue, chikungunya e Zika), Semanas Epidemiológicas 01 a 52. Boletim Epidemiológico. 2020;2:1-11. Disponível em: https://www.gov.br/saude/pt-br.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Monitoramento dos casos de arboviroses até a semana epidemiológica 18 de 2022. Boletim Epidemiológico. 2022;53:1-40. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/edicoes/2022/boletim-epidemiologico-vol-53-no18.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em saúde. Monitoramento dos casos de dengue, febre de chikungunya e febre pelo vírus Zika até a semana Epidemiológica 52, 2016. Boletim Epidemiológico. 2017;48:1-11. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/edicoes/2022/boletim-epidemiologico-vol-53-no18.
CARDOSO, A. C. A. et al. Associação entre a infecção por Chikungunya Vírus e o desenvolvimento de formas graves da doença: uma revisão sistemática. Revista Eletrônica Acervo Saúde, v. 11, n. 15, p. e1066, 31 ago. 2019.
DE OLIVEIRA, B. F. A. et al. Pilates method in the treatment of patients with Chikungunya fever: a randomized controlled trial. Clinical Rehabilitation, v. 33, n. 10, p. 1614–1624, out. 2019.
DORAN, C. et al. Long-term Chikungunya sequelae and quality of life 2.5 years post-acute disease in a prospective cohort in Curaçao. PLoS neglected tropical diseases, v. 16, n. 3, p. e0010142, mar. 2022.
FNS. Fundação Nacional de Saúde. Programa Nacional de Controle da Dengue-PNCD. Brasília. 2002. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/pncd_2002.pdf.
HAMMON, W. M.; RUDNICK, A.; SATHER, G. E. Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand. Science (New York, N.Y.), v. 131, n. 3407, p. 1102–1103, 15 abr. 1960.
MARQUES, C. D. L. et al. Recommendations of the Brazilian Society of Rheumatology for the diagnosis and treatment of chikungunya fever. Part 2 - Treatment. Revista Brasileira De Reumatologia, v. 57 Suppl 2, p. 438–451, 2017.
MUSSO, D.; GUBLER, D. J. Zika Virus. Clinical Microbiology Reviews, v. 29, n. 3, p. 487–524, jul. 2016.
NEUMANN, I. L. et al. Resistance exercises improve physical function in chronic Chikungunya fever patients: a randomized controlled trial. European Journal of Physical and Rehabilitation Medicine, v. 57, n. 4, p. 620–629, ago. 2021.
NUNES, M. R. T. et al. Emergence and potential for spread of Chikungunya virus in Brazil. BMC medicine, v. 13, p. 102, 30 abr. 2015.
PAIXÃO, E. S. et al. Chikungunya chronic disease: a systematic review and meta-analysis. Transactions of the Royal Society of Tropical Medicine and Hygiene, v. 112, n. 7, p. 301–316, 1 jul. 2018.
PEGADO, R.; CAVALCANTE, A. F.; MORYA, E. Newer rehabilitation therapies: strategies in chikungunya chronic arthralgia. Clinical Medicine, v. 20, n. 1, p. 119–120, jan. 2020.
RODRIGO, C. et al. Treatment of chikungunya-associated joint pain: a systematic review of controlled clinical trials. Transactions of the Royal Society of Tropical Medicine and Hygiene, v. 116, n. 10, p. 889–899, 2 out. 2022.
RODRIGUES FARIA, N. et al. Epidemiology of Chikungunya Virus in Bahia, Brazil, 2014-2015. PLoS currents, v. 8, p. ecurrents.outbreaks.c97507e3e48efb946401755d468c28b2, 1 fev. 2016.
SALVADOR, F. S.; FUJITA, D. M. Entry routes for Zika virus in Brazil after 2014 world cup: New possibilities. Travel Medicine and Infectious Disease, v. 14, n. 1, p. 49–51, 2016.
YOUNG, D. R. et al. Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart Association. Circulation, v. 134, n. 13, p. e262-279, 27 set. 2016.
Téléchargements
Publiée
Comment citer
Numéro
Rubrique
Licence
Ce travail est disponible sous licence Creative Commons Attribution - Pas d’Utilisation Commerciale 4.0 International.
